Non-alcoholic beer
Dietary SupplementTreatment consisted of 330ml non-alcoholic beer per day, plus an individualized dietary program and an exercise program with a pedometer-based bracelet to reach at least 5000 steps/day during 2 + 8 weeks.
NCT Number: NCT04041115
The implementation of nutritional strategies targeting several variables at once could benefit patients with cirrhosis. Non-alcoholic beer has different compounds derived from hops that exert antioxidant, anti-inflammatory and nutritional properties. The aim of this study is to evaluate the effect of diet + exercise and non-alcoholic beer on nutritional status, endothelial function and quality of life in patients with cirrhosis.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment consisted of 330ml non-alcoholic beer per day, plus an individualized dietary program and an exercise program with a pedometer-based bracelet to reach at least 5000 steps/day during 2 + 8 weeks.
Treatment consisted of 330ml of water, plus an individualized dietary program and an exercise program with a pedometer-based bracelet to reach at least 5000 steps/day during 2 + 8 weeks.
Time frame: 8 weeks
improvement in impedance-derived phase angle (PhA)
Time frame: 8 weeks
improvement in flow-mediated dilation (brachial artery)
Time frame: 8 weeks
improvement in serum markers of endothelial function (v.gr. nitric oxide, NO; prostacyclin, PGI2, etc.)
Time frame: 8 weeks
Improvement in quality of life questionnaire CLDQ (chronic liver disease questionnaire)
Time frame: 8 weeks
Changes in the heterogeneity of fecal microbiota in terms of bacterial diversity will be assessed
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Other
Effect of a Multifactorial Intervention (Non-alcoholic Beer, Diet and Exercise) on Endothelial Function, Nutritional Status and Quality of Life in Patients With Cirrhosis
Acronym: LFN-NAB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05379608
Arrhythmia, Arrhythmias, Cardiac
Moscow, Russia
View Trial DetailsNCT02838979
Atrophy, Cardiovascular Disease
Seattle, Washington, United States
View Trial DetailsNCT01642576
Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Singapore
View Trial DetailsNCT01554865
Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Singapore
View Trial Details